Mindset Files Articles of Incorporation and Elects Board of Directors
October 7, 2019
Following months of research and planning, Mindset Pharma Inc. (“Mindset” or the “Company”) has been officially incorporated in Ontario effective today. Mindset’s is a psychedelic-based drug discovery business incorporated for the purpose of creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. The Initial directors of Mindset are: Joseph Araujo – President and CEO of InterVivo Solutions, which is focused on optimizing translational services to facilitate the development and approval of novel central nervous system (“CNS”) drugs. Joseph has graduate training in pharmacology at the University of Toronto and more than 35 refereed publications and several invited presentations, which focus on natural aged canine models of human disease. He has co-founded, held executive level positions and consulted for Life Science companies including CanCog Technologies, Vivocore, Karyopharm Therapeutics, NPM Pharma, Ketogen, and Epione Animal Health. Joseph has done extensive research examining psychoactive drugs. James Passin - A 19-year hedge fund and private equity fund veteran with a deep experience in emerging market equities and venture capital. James is a director of BDSec JSC, the largest investment bank in Mongolia, where he was awarded the Friendship Medal by the Mongolian state. Formerly a Principal at New York based Firebird Management LLC, James has been called a “Daredevil Investor” by the New York Times and “the Indiana Jones of Frontier Stock Markets” by the Financial Times. Richard Patricio - President and CEO of Mega Uranium Ltd., a uranium focused investment and development company with assets in Canada and Australia. He is a qualified lawyer (Ontario) with over 15 years of experience working with and for public companies. He has built a number of mining companies with global operations and spent 10 years with a TSX listed investment company focused in the early stage investment space. Richard holds and has held senior officer and director positions in several companies that are listed on the TSX, ASX, NYSE and AIM exchanges. Richard received his law degree from Osgoode Hall and was called to the Ontario bar in 2000. Philip Williams - More than 20 years of finance industry experience. His diverse experience includes roles as C-Suite Executive, as a sell side research analyst, in fund management, managing director of investment banking and sits on the Board of several public companies in Canada. Mindset intends on building out its business plan and management team aggressively as it considers the psychedelic pharma to be an ever-growing space in the science and business world in the next decade.
About Mindset Pharma
Mindset Pharma is a drug discovery business focused on creating novel and patentable psychedelic compounds for the treatment of neurological and psychiatric disorders. Founded by serial entrepreneurs and domain experts in drug development and medicinal chemistry and based in Toronto, Canada, Mindset is assembling a proprietary library of transformative psychedelic intellectual property designed to address chronic neuropsychiatric disorders efficiently and safely.